Nsc290127
|
- $180
- Product name: Nsc290127
- CAS: 66845-32-7
- MF: C6H14I2N2Pt
- MW: 563.0757
- EINECS:
- MDL Number:
- Synonyms:Nsc290127;Oxaliplatin Related Compound F (25 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') diiodidoplatinum(II));Oxaliplatin Related CoMpound F;Diiodo(trans-l-1,2-cyclohexanediamine)platinum;(trans-R,R-1,2-Diaminocyclohexane)diiodoplatinum;(trans-1R,2R-1,2-Diaminocyclohexane)diiodoplatinum;[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum;Oxaliplatin Related Compound F (25 mg)
1 prices
Selected condition:
Brand
- TRC
Package
- 25mg
- ManufacturerTRC
- Product numberC984525
- Product description[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN'')Diiodoplatinum
- Packaging25mg
- Price$180
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| TRC | C984525 | [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN'')Diiodoplatinum | 25mg | $180 | 2021-12-16 | Buy |
Properties
Melting point :>300°C
storage temp. :-20°C Freezer
solubility :DMSO (Slightly)
form :Solid
color :Light Yellow
Major Application :pharmaceutical (small molecule)
InChI :1S/C6H12N2.2HI.Pt/c7-5-3-1-2-4-6(5)8;;;/h5-8H,1-4H2;2*1H;/q-2;;;+4/p-2
InChIKey :KEZVWGKGXZSYRH-UHFFFAOYSA-L
SMILES :[Pt+2](I)I.[N-H]C1C(CCCC1)[N-H]
storage temp. :-20°C Freezer
solubility :DMSO (Slightly)
form :Solid
color :Light Yellow
Major Application :pharmaceutical (small molecule)
InChI :1S/C6H12N2.2HI.Pt/c7-5-3-1-2-4-6(5)8;;;/h5-8H,1-4H2;2*1H;/q-2;;;+4/p-2
InChIKey :KEZVWGKGXZSYRH-UHFFFAOYSA-L
SMILES :[Pt+2](I)I.[N-H]C1C(CCCC1)[N-H]
Safety Information
| Symbol(GHS): |
![]() ![]()
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN'')diiodoplatinum is a potential antitumor agent. Impurity of Oxiplatin (O845075), third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.Suppliers and manufacturers
Moxin Chemicals
Quality Control Solutions Ltd.
Beijing Solarbio Science & Tecnology Co., Ltd.
Energy Chemical
LGC Science (Shanghai) Ltd.
Shanghai Haohong Scientific Co., Ltd.
Nantong Hanfang Biotechnology Co. , Ltd.
Hubei Moco Chemical Co., Ltd.
Merck KGaA
Changzhou Xianglong Pharmaceutical Technology Co., Ltd.,






